EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Induced Tumor-Suppressing (iTS) Cell-Based Approach for Protecting the Bone from Advanced Prostate Cancer

Shengzhi Liu iD, Di Wu, Kazumasa Minami iD, Jing Liu, Sungsoo Na iD, Uma K Aryal iD, Marxa L Figueiredo iD, Alexander G Robling, Bai-Yan Li iD, Hiroki Yokota iD

Biomolecules · 2026

DOI: 10.3390/biom16020240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Shengzhi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Neoplasms, Microfilament Proteins. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, R&D Program of Beijing Municipal Education Commission, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced prostate cancer frequently metastasizes to bone, but no effective therapy exists. To seek a novel treatment option and identify a new drug target, we took an induced tumor-suppressing (iTS) cell-based approach and produced tumor-suppressing proteins and conditioned medium (CM). Notably, the overexpression of Lrp5 and β-catenin, as well as the pharmacological Wnt activator, converted osteocytes, Murine mesenchymal stem cells, mononuclear cells, and monocytes into iTS cells. While Lrp5 conditional knockout mice presented severe bone loss, Lrp5-overexpressing osteocyte-derived CM rescued tumor-induced bone damage. Whole-genome proteomics analysis revealed that Moesin (MSN), which acted as an oncogene in tumor cells, was enriched in CM as an extracellular tumor-suppressing protein. Its anti-tumor action was mediated primarily by the interaction with CD44. Consistently, FRET live-cell imaging demonstrated that extracellular MSN reduced Src tyrosine kinase activity and nuclear localization of β-catenin. Collectively, we demonstrated herein the iTS cell-based approach to protect bone from prostate cancer and showed MSN as a potent extracellular tumor-suppressing protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBone NeoplasmsMicrofilament ProteinsMaleAnimalsMiceHumansbeta CateninOsteocytesCulture Media, ConditionedLow Density Lipoprotein Receptor-Related Protein-5Mice, KnockoutCell Line, TumorMesenchymal Stem Cells

Stichwörter der Autor:innen

CD44Lrp5MSCMoesinboneiTS cellsosteocytesprostate cancer

Substanzen

beta CateninmoesinMicrofilament ProteinsCulture Media, ConditionedLow Density Lipoprotein Receptor-Related Protein-5

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
  • Weldon School of Biomedical Engineering, Purdue University Indianapolis, Indianapolis, IN 46202, USA.
  • Department of Pharmacology, School of Pharmacy, Harbin Medical University, Harbin 150081, China.
  • Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Department of Physics and Astronomy, Purdue University, West Lafayette, IN 47907, USA.
  • Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74075, USA.

ORCID-Profile: Shengzhi Liu, Kazumasa Minami, Sungsoo Na, Uma K Aryal, Marxa L Figueiredo, Bai-Yan Li, Hiroki Yokota

Förderung

  • National Natural Science Foundation of China
  • R&D Program of Beijing Municipal Education Commission
  • NIAMS NIH HHS
  • NCI NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Cancer Institute

Zitieren

APA

Liu, S., Wu, D., Minami, K., Liu, J., Na, S., Aryal, U. K., Figueiredo, M. L., Robling, A. G., Li, B. Y., & Yokota, H. (2026). Induced Tumor-Suppressing (iTS) Cell-Based Approach for Protecting the Bone from Advanced Prostate Cancer. Biomolecules. https://doi.org/10.3390/biom16020240

Vancouver

Liu S, Wu D, Minami K, Liu J, Na S, Aryal UK, et al. Induced Tumor-Suppressing (iTS) Cell-Based Approach for Protecting the Bone from Advanced Prostate Cancer. Biomolecules. 2026. doi:10.3390/biom16020240

BibTeX
@article{Liu2026,
  author = {Liu, Shengzhi and Wu, Di and Minami, Kazumasa and Liu, Jing and Na, Sungsoo and Aryal, Uma K and Figueiredo, Marxa L and Robling, Alexander G and Li, Bai-Yan and Yokota, Hiroki},
  title = {Induced Tumor-Suppressing (iTS) Cell-Based Approach for Protecting the Bone from Advanced Prostate Cancer},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16020240}
}
Kostenlos starten →